In 2018, Prevention magazine included Madabhushi's work on “Smart Imaging Computers” for identifying lung cancer patients who could benefit from chemotherapy on a list called “The 10 Most Incredible Medical Breakthroughs of 2018”.
At the time of this writing, Dr. Madabhushi holds the position of Donnell Institute Professor and serves as the director of the university's Center for Computational Imaging and Personalized Diagnostics (CCIPD).
[13][14][15][16] With Madabhushi as founding director, the team at Case Western Reserve University's Center for Computational Imaging and Personalized Diagnostics (CCIPD) is “involved in various different aspects of developing, evaluating and applying novel quantitative image analysis, computer vision, signal processing, segmentation, multi-modal co-registration tools, pattern recognition, and machine learning tools for disease diagnosis, prognosis, and theragnosis in the context of breast, prostate, head and neck, and brain tumors as well as epilepsy and carotid plaque.
Our group is also exploring the utility of these methods in studying correlations of disease markers across multiple scales, modalities, and functionalities -- from gene and protein expression to spectroscopy to digital pathology and to multi-parametric MRI.
Madabhushi has been involved in sponsored research and industry collaborations with companies including Siemens,[19] Astrazeneca,[20] Boehringer Ingelheim[21] and Bristol Myers Squibb.